Recovery of kidney function following delayed use of theralite™ dialyzer in a patient with myeloma cast nephropathy

Clinical Nephrology

Volumn 79, Issue 4, 2013, Pages 318-322

  Dahal, Khagendra ^a   Shastri, Shani ^a   Narayanasami, Uma ^a,b   Bijol, Vanesa ^c   Rider, Karen ^a   Strom, James A ^a,b   Jaber, Bertrand L ^a,b  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute kidney injury; Cast nephropathy; Hemodialysis; High cut off dialyzer; Myeloma; Theralite

Indexed keywords

ALBUMIN; BORTEZOMIB; CD38 ANTIGEN; CD56 ANTIGEN; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN KAPPA CHAIN; LENALIDOMIDE; NAPROXEN; NITROGEN; POTASSIUM; STEM CELL FACTOR RECEPTOR; SYNDECAN 1; UREA;

ACIDOSIS; ACUTE KIDNEY FAILURE; ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; ARTIFICIAL KIDNEY; BONE ATROPHY; BONE MARROW BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; FLOW CYTOMETRY; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERVOLEMIA; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; LEUKOCYTE; LOW BACK PAIN; MALE; MYELOMA; MYELOMA CAST NEPHROPATHY; NAUSEA AND VOMITING; PLASMAPHERESIS; POLYURIA; POTASSIUM BLOOD LEVEL; PROTEIN ELECTROPHORESIS; RADIOTHERAPY; SEIZURE; SLEEP DISORDERED BREATHING; STEM CELL TRANSPLANTATION; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINE SEDIMENT;

ACUTE KIDNEY INJURY; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; EQUIPMENT DESIGN; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; KIDNEY; KIDNEYS, ARTIFICIAL; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLASMAPHERESIS; RECOVERY OF FUNCTION; RENAL DIALYSIS; STEM CELL TRANSPLANTATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84877318286     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107357     Document Type: Article

References (16)

1. Knudsen LM, Hippe E, Hjorth M, Holmberg E, Westin J; The Nordic Myeloma Study Group. Renal function in newly diagnosed multiple myeloma - a demographic study of 1353 patients. Eur J Haematol. 1994; 53: 207-212. doi:10.1111/j.16 00-0 609.1994.tb00190.x PubMed
2. Knudsen LM, Hjorth M, Hippe E; Nordic Myeloma Study Group. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Eur J Haematol. 2000; 65: 175-181. doi:10.1034/ j.1600-0609.2000.90221.x PubMed
3. Smith A, Wisloff F, Samson D; UK Myeloma ForumNordic Myeloma Study Group; British Committee for Standards in Haematology. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol. 2006; 132: 410-451. doi:10.1111/j.1365-2141.2005.05867.x PubMed
4. Clark WF, Stewart AK, Rock GA, Sternbach M, Sutton DM, Barrett BJ, Heidenheim AP, Garg AX, Churchill DN; Canadian Apheresis Group. Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial. Ann Intern Med. 2005; 143: 777-784. PubMed
5. Leung N, Gertz MA, Zeldenrust SR, Rajkumar SV, Dispenzieri A, Fervenza FC, Kumar S, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Hayman SR, Russell SJ, Kyle RA, Winters JL. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int. 2008; 73: 1282-1288. doi:10.1038/ki.2008.108 PubMed
6. Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M, Goehl H, Storr M, Bradwell AR; Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Nephrol. 2007; 18: 886-895. doi:10.1681/ ASN.2006080821 PubMed
7. Hutchison CA, Bradwell AR, Cook M, Basnayake K, Basu S, Harding S, Hattersley J, Evans ND, Chappel MJ, Sampson P, Foggensteiner L, Adu D, Cockwell P; Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol. 2009; 4: 745-754. doi:10.2215/ CJN.04590908 PubMed
8. Goldschmidt H, Lannert H, Bommer J, Ho AD; Multiple myeloma and renal failure. Nephrol Dial Transplant. 2000; 15: 301-304. doi:10.1093/ ndt/15.3.301 PubMed
9. Cserti C, Haspel R, Stowell C, Dzik W; Light-chain removal by plasmapheresis in myeloma-associated renal failure. Transfusion. 2007; 47: 511-514. doi:10.1111/j.1537-2995.2006.01143.x PubMed
10. Immunoglobulins free light chains Kappa and Lambda (FLC). (Accessed on January 5, 2011, at http://www.biovendor.com/molecule/immunoglobulin-free-light-chains-kappa-and-lambda)
11. Shum HP, Chan KC, Chow CC, Kho BC, Yan WW;. Cast nephropathy with acute renal failure treated with high cut-off haemodialysis in a patient with multiple myeloma. Hong Kong Med J. 2010; 16: 489-492. PubMed
12. Hutchison CA, Cook M, Heyne N, Weisel K, Billingham L, Bradwell A, Cockwell P; European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial. Trials. 2008; 9: 55. doi:10.1186/1745- 6215-9-55 PubMed
13. Manochakian R, Miller KC, Chanan-Khan AA; Clinical impact of bortezomib in frontline regimens for patients with multiple myeloma. Oncologist. 2007; 12: 978-990. doi:10.1634/theoncologist. 12-8-978 PubMed
14. Basnayake K, Cheung CK, Sheaff M, Fuggle W, Kamel D, Nakoinz S, Hutchison CA, Cook M, Stoves J, Bradwell AR, Cockwell P; Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney. J Clin Pathol. 2010; 63: 884-887. doi:10.1136/ jcp.2010.079236 PubMed
15. Premru V, Kovac J, Buturovic-Ponikvar J, Ponikvar R;. High cut-off membrane hemodiafiltration in myoglobinuric acute renal failure: a case series. Ther Apher Dial. 2011; 15: 287-291. doi:10.1111/ j.1744-9987.2011.00953.x PubMed
16. Gondouin B, Hutchison CA; High cut-off dialysis membranes: current uses and future potential. Adv Chronic Kidney Dis. 2011; 18: 180-187. doi:10.1053/j.ackd.2011.02.006 PubMed